Distinct Expression of Galectin-3 in Pheochromocytomas
Authors:
- 1 August 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1073 (1) , 571-577
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene MutationsJAMA, 2004
- Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3Oncogene, 2004
- From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodulesBiomedicine & Pharmacotherapy, 2004
- Expression Profile of the Telomeric Complex Discriminates between Benign and Malignant PheochromocytomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- Galectin-3 and metastasisGlycoconjugate Journal, 2002
- Differential Reactivity for Galectin-3 in Hürthle Cell Adenomas and CarcinomasEndocrine Pathology, 2001
- Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?The Journal of Pathology, 2000
- Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid TumorsThe American Journal of Pathology, 2000
- Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferationCancer, 1999
- Lectins in the cell nucleusGlycobiology, 1991